KANJINTI
Used for Cancer
Are you tired of high medication costs? Our service offers unbeatable savings on your KANJINTI prescription medication. We provide a range of solutions to help you save up to 100% on your medication costs*. Whether you are insured, uninsured, underinsured, or simply looking to reduce your out-of-pocket expenses, we've got you covered.
Manufactured by Amgen Inc.
*You can pay as little as $0 per fill using Drug Coupons or Patient Assistance Programs. Subject to applicability & eligibility requirements.
This content is intended for US audiences only
How can I lower the cost of my KANJINTI?
You can lower cost of your KANJINTI using one of the 4 following drug savings programs
Start Saving Today!
Lower the cost of your KANJINTI prescription
Join the many satisfied customers who have already benefited from our prescription discount programs.
Comprehensive Coverage
Our service covers a wide range of medications, ensuring you can find savings on almost any prescription.
Easy to Use
Our website is user-friendly, allowing you to quickly find and apply discounts.
Trusted by Many
Thousands of users trust us to help them save on their medication costs every day.
KANJINTI Uses, Side Effects, Interactions, Warnings & Dosing
What is KANJINTI?
KANJINTI is the brand name for trastuzumab-ann subcutaneous injection and IV infusion.
What dosages is KANJINTI available in?
KANJINTI is available as 150 mg and 420 mg used for injection.
What is KANJINTI used for?
KANJINTI is a monoclonal antibody that is used to treat:
- HER2-positive, breast cancers – IV and SQ injections
- HER2-positive, metastatic stomach cancer – IV injection only
How does KANJINTI work?
KANJINTI is a monoclonal antibody that acts as a human epidermal growth factor receptor 2 (HER2) inhibitor. It blocks a specific protein in the body that’s important for cell growth called HER2. HER2 is found on both normal and cancer cells. Cancer cells usually have more HER2 proteins than normal cells. This can cause cancer cells to grow more quickly than normal cells. When HER2 is blocked by KANJINTI, cancer cells can’t grow and spread as well.
How do I take KANJINTI?
KANJINTI dose for IV infusion is based on weight and given over 30 to 90 minutes. The dose for a subcutaneous injection is not based on weight.
Is it safe for me to take KANJINTI?
KANJINTI is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
KANJINTI Common Side Effects
Common side effects of KANJINTI:
- Body and joint pain
- Weakness
- Fever
- Nausea
- Chills
- Headache
- Cough
- Diarrhea
- Vomiting
- Infection
KANJINTI Serious Side Effects
Serious side effects are rare with KANJINTI. Contact your healthcare provider immediately if you experience any of the following.
- Heart problems: chest pain, racing heartbeat, shortness of breath that usually worsens with activity or while lying flat, swelling of your legs or feet, sudden weight gain, fatigue
- Serious infusion reactions: trouble breathing, itching or hives, flushing, swelling, chest pain, fast heartbeat, dizziness, fainting
- Lung problems: shortness of breath, trouble breathing
Serious infections (when receiving in combination with chemotherapy): repeated fevers, chills, sweating, cough, trouble breathing, severe diarrhea, vomiting, painful or frequent urination
Effects of other drugs, drug classes and over-the-counter products on KANJINTI
The following medications may interact with KANJINTI:
- Patients who receive anthracycline after stopping trastuzumab products may be at increased risk of cardiac dysfunction because of KANJINTI’s long washout period based. If possible, physicians should avoid anthracycline-based therapy for up to 7 months after stopping KANJINTI products
- If anthracyclines are used, the patient’s cardiac function should be monitored carefully
Who makes KANJINTI?
Amgen Inc.
Is KANJINTI safe in pregnancy?
KANJINTI can cause fetal harm when administered to a pregnant woman. Pregnant women and females of reproductive that take KANJINTI during pregnancy or within 7 months prior to conception can result in fetal harm. Contact your healthcare provider with a known or suspected pregnancy. Females who can become pregnant should use effective contraception during treatment and for 7 months following the last dose of KANJINTI.
The FDA's medical product safety reporting program for health professionals, patients and consumers.
Learn more about reporting side effects
Drug Savings Tips
How can NowPatient help me to lower the cost of my KANJINTI prescription?
How do the NowPatient KANJINTI savings programs work?
Are the NowPatient KANJINTI savings programs suitable for everyone, regardless of insurance status?
Are the NowPatient drug savings programs suitable for brand and generic versions of KANJINTI?
If you have Medicare Part D or Medicare Advantage and none of the KANJINTI savings options are applicable or affordable for me, what can you do?
I am uninsured or underinsured and none of the KANJINTI prescription saving options are applicable or affordable for me, what can I do?
I am commercially or privately insured and none of the KANJINTI prescription saving options are applicable or affordable for me, what can I do?
If I have federal, state or commercial insurance and none of the KANJINTI prescription saving options are applicable or affordable for me, are there any other support organisations that can help me with my co-insurance or copay?
Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
WHY WE BUILT NOWPATIENT
To improve the lives of everyone by making high-quality care accessible and convenient
We are here to improve lives. Our service gives you access to smart features and resources that can help empower you to take control of your health and improve your health outcomes. All this, in one place, for FREE. We strive to bring a fresh perspective to managing health. NowPatient can be accessed by downloading the App or using your web browser.
Download our app today
Your Questions Answered
For your peace of mind, we can answer your questions quickly
